• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-34a通过转化生长因子-β途径促进肝星状细胞纤维化。

MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway.

作者信息

Zhang Jie, Wang Haixia, Yao Linlin, Zhao Peng, Wu Xiaoyan

机构信息

Department of Nutrition, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Department of Nutrition, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

出版信息

Ann Transl Med. 2021 Oct;9(20):1520. doi: 10.21037/atm-21-5005.

DOI:10.21037/atm-21-5005
PMID:34790726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8576652/
Abstract

BACKGROUND

Previous studies have confirmed that MicroRNA (miRNA) is a key regulator exhibiting different effects in human liver fibrosis. However, the function of miR-34a in liver fibrosis has not been reported. Hence, this study aimed to investigate the regulatory mechanism of miR-34a in liver fibrosis.

METHODS

The expression of miR-34a was measured in fibrosis tissues via the quantitative real-time PCR (qRT-PCR) assay. Subsequently, 30 male C57BL/6J mice were divided into control and treatment groups and used to establish animal models of liver fibrosis to explore the expression level of miR-34a. Moreover, Cell Counting Kit 8 (CCK-8) and transwell assays were preformed to identify the regulatory mechanism of miR-34a in cells. The effect of miR-34a on the activity of transforming growth factor-β (TGF-β) pathway was observed by western blot.

RESULTS

Up-regulation of miR-34a was detected in fibrosis cells. Moreover, the cellular phenotype was suppressed by miR-34a down-regulation in a primary culture of hepatic stellate cells (HSCs). Besides, it was found that increased miR-34a could significantly promote the invasion and migration of HSCs. Moreover, miR-34a activates HSCs through transforming TGF-β, α-smooth muscle actin (α-SMA), and Monocyte chemoattractant protein-1 (MCP-1), which further affects liver fibrosis.

CONCLUSIONS

MiR-34a promotes the fibrosis of HSCs as well as cell proliferation, migration, and invasion.

摘要

背景

先前的研究已证实,微小RNA(miRNA)是一种关键调节因子,在人类肝纤维化中发挥着不同作用。然而,miR-34a在肝纤维化中的功能尚未见报道。因此,本研究旨在探讨miR-34a在肝纤维化中的调控机制。

方法

通过定量实时聚合酶链反应(qRT-PCR)检测纤维化组织中miR-34a的表达。随后,将30只雄性C57BL/6J小鼠分为对照组和治疗组,用于建立肝纤维化动物模型,以探究miR-34a的表达水平。此外,进行细胞计数试剂盒8(CCK-8)和transwell实验,以确定miR-34a在细胞中的调控机制。通过蛋白质免疫印迹法观察miR-34a对转化生长因子-β(TGF-β)信号通路活性的影响。

结果

在纤维化细胞中检测到miR-34a上调。此外,在肝星状细胞(HSCs)原代培养中,miR-34a下调可抑制细胞表型。此外,发现miR-34a增加可显著促进HSCs的侵袭和迁移。此外,miR-34a通过转化TGF-β、α-平滑肌肌动蛋白(α-SMA)和单核细胞趋化蛋白-1(MCP-1)激活HSCs,进而影响肝纤维化。

结论

MiR-34a促进HSCs纤维化以及细胞增殖、迁移和侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/926c414a46b6/atm-09-20-1520-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/1e26422e4781/atm-09-20-1520-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/2bf785ec0722/atm-09-20-1520-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/74233dfb4a2e/atm-09-20-1520-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/aa93e08d0e34/atm-09-20-1520-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/ed9b8a4ee359/atm-09-20-1520-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/926c414a46b6/atm-09-20-1520-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/1e26422e4781/atm-09-20-1520-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/2bf785ec0722/atm-09-20-1520-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/74233dfb4a2e/atm-09-20-1520-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/aa93e08d0e34/atm-09-20-1520-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/ed9b8a4ee359/atm-09-20-1520-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e04/8576652/926c414a46b6/atm-09-20-1520-f6.jpg

相似文献

1
MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway.微小RNA-34a通过转化生长因子-β途径促进肝星状细胞纤维化。
Ann Transl Med. 2021 Oct;9(20):1520. doi: 10.21037/atm-21-5005.
2
PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of and in hepatic stellate cells.PU.1 缺陷型小鼠对硫代乙酰胺诱导的肝纤维化具有抗性:PU.1 通过对肝星状细胞中 和 的转录促进来精细调节 Sirt1 的表达。
Biosci Rep. 2017 Dec 12;37(6). doi: 10.1042/BSR20170926. Print 2017 Dec 22.
3
MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.微小 RNA-34a-5p 通过调控肝星状细胞中 TGF-β1/Smad3 通路抑制肝纤维化。
Cell Biol Int. 2018 Sep;42(10):1370-1376. doi: 10.1002/cbin.11022. Epub 2018 Aug 10.
4
MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1.微小RNA-34a通过靶向ACSL1促进肝星状细胞激活。
Med Sci Monit. 2015 Oct 6;21:3008-15. doi: 10.12659/MSM.894000.
5
Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.表观遗传调控的微小RNA-9-5p通过转化生长因子β受体1和转化生长因子β受体2抑制肝星状细胞的激活。
Cell Physiol Biochem. 2017;43(6):2242-2252. doi: 10.1159/000484303. Epub 2017 Oct 27.
6
MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.肝吸虫诱导的 microRNA-497 通过靶向 Smad7 增强 TGF-β/Smad 信号通路促进肝纤维化。
Parasit Vectors. 2021 Sep 14;14(1):472. doi: 10.1186/s13071-021-04972-3.
7
miR-21 promotes proliferation and inhibits apoptosis of hepatic stellate cells through targeting PTEN/PI3K/AKT pathway.微小RNA-21通过靶向磷脂酰肌醇-3-激酶/蛋白激酶B通路促进肝星状细胞增殖并抑制其凋亡。
J Recept Signal Transduct Res. 2018 Oct-Dec;38(5-6):455-461. doi: 10.1080/10799893.2019.1585452.
8
miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.微小RNA-144调节转化生长因子-β1诱导的人纤维化肝脏中肝星状细胞的激活。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3994-4000. eCollection 2015.
9
Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis regulation of TGF-β/Smad signaling pathway.骨形态发生蛋白-7 抑制肝星状细胞活化和肝纤维化——调节 TGF-β/Smad 信号通路。
World J Gastroenterol. 2019 Aug 14;25(30):4222-4234. doi: 10.3748/wjg.v25.i30.4222.
10
MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.微小RNA-30通过减弱肝星状细胞中的转化生长因子β信号传导来预防四氯化碳诱导的肝纤维化。
Toxicol Sci. 2015 Jul;146(1):157-69. doi: 10.1093/toxsci/kfv081. Epub 2015 Apr 24.

引用本文的文献

1
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?酒精性肝病和肝细胞癌中的微小RNA:迈向新治疗方法的一步?
Cancers (Basel). 2023 Nov 23;15(23):5557. doi: 10.3390/cancers15235557.
2
Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression.肝脏来源的微小RNA在代谢性疾病进展中的器官间串扰及预后作用洞察
Biomedicines. 2023 May 31;11(6):1597. doi: 10.3390/biomedicines11061597.
3
ER stress induces myocardial dysfunction and cardiac autophagy in Sestrin2 knockout mice.

本文引用的文献

1
Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma.从肝纤维化到肝硬化和肝细胞癌的进展中的血管生成。
Expert Rev Gastroenterol Hepatol. 2021 Mar;15(3):217-233. doi: 10.1080/17474124.2021.1842732. Epub 2020 Nov 11.
2
Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways.连翘果实水提物通过 TLR4/MyD88/NF-κB 和 TGF-β/smads 信号通路减轻肝纤维化。
J Ethnopharmacol. 2020 Nov 15;262:113275. doi: 10.1016/j.jep.2020.113275. Epub 2020 Aug 15.
3
LncRNA Mical2/miR-203a-3p sponge participates in epithelial-mesenchymal transition by targeting p66Shc in liver fibrosis.
内质网应激在Sestrin2基因敲除小鼠中诱导心肌功能障碍和心脏自噬。
Am J Transl Res. 2022 Aug 15;14(8):5800-5811. eCollection 2022.
4
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.miR-488-5p 通过抑制 TET3 表达减轻肝星状细胞活化和肝纤维化。
Hepatol Int. 2023 Apr;17(2):463-475. doi: 10.1007/s12072-022-10404-w. Epub 2022 Aug 24.
5
MicroRNA-34a: A Novel Therapeutic Target in Fibrosis.微小RNA-34a:纤维化中的新型治疗靶点。
Front Physiol. 2022 Jun 20;13:895242. doi: 10.3389/fphys.2022.895242. eCollection 2022.
长链非编码 RNA Mical2/miR-203a-3p 海绵通过靶向 p66Shc 参与肝纤维化中的上皮-间充质转化。
Toxicol Appl Pharmacol. 2020 Sep 15;403:115125. doi: 10.1016/j.taap.2020.115125. Epub 2020 Jul 11.
4
Deep residual nets model for staging liver fibrosis on plain CT images.基于平扫 CT 图像的肝纤维化分期的深度残差网络模型。
Int J Comput Assist Radiol Surg. 2020 Aug;15(8):1399-1406. doi: 10.1007/s11548-020-02206-y. Epub 2020 Jun 16.
5
Research on promoting liver fibrosis injury by the targeted regulation of miR-202 for HGF to activate HSC.研究通过靶向调控 miR-202 促进 HGF 激活 HSC 导致肝纤维化损伤。
Ir J Med Sci. 2020 Nov;189(4):1295-1304. doi: 10.1007/s11845-020-02210-w. Epub 2020 Apr 9.
6
Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connetive Tissue Growth Factor.Src 抑制通过防止肝星状细胞活化和减少结缔组织生长因子来减轻肝纤维化。
Cells. 2020 Feb 27;9(3):558. doi: 10.3390/cells9030558.
7
miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway.miR-34a 通过介导 Sirt1/p53 信号通路促进慢性肝炎患者肝纤维化。
Pathol Res Pract. 2020 May;216(5):152876. doi: 10.1016/j.prp.2020.152876. Epub 2020 Feb 13.
8
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.共生元改变粪便微生物组,但不能改变非酒精性脂肪性肝病患者的肝脏脂肪或纤维化:一项随机试验。
Gastroenterology. 2020 May;158(6):1597-1610.e7. doi: 10.1053/j.gastro.2020.01.031. Epub 2020 Jan 25.
9
Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway.五味子乙素通过靶向 TGF-β 信号通路抑制 miR-101-5p 抑制大鼠肝纤维化。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):473-478. doi: 10.1080/21691401.2020.1717507.
10
Diagnostic Performance of Serum Asialo-α1-acid Glycoprotein for Advanced Liver Fibrosis or Cirrhosis in Patients with Chronic Hepatitis B or Nonalcoholic Fatty Liver Disease.血清去唾液酸α1-酸性糖蛋白对慢性乙型肝炎或非酒精性脂肪性肝病患者晚期肝纤维化或肝硬化的诊断效能
Korean J Gastroenterol. 2019 Dec 25;74(6):341-348. doi: 10.4166/kjg.2019.74.6.341.